Delivery Order SPE2DR25D2014-SPE2DR26FZ85E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,452.05 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of AVEED 750 mg/3 mL vials. The contract represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a $34,684.92 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract is competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 5, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of AVEED 750 mg/3 mL vials. This firm fixed-price delivery order, valued at $6,092.16, is set to be completed by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the company's demonstrated capability to meet federal...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of AVEED 750 MG/3 ML vials. The contract, valued at $23,123.28, carries a firm fixed price and requires completion by June 23, 2025. This is a non-set-aside delivery order issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of AVEED 750 mg/3 mL vials. The order carries a ceiling value of $34,684.92 and is structured as a firm fixed-price delivery order with an ultimate completion date of June 23, 2025. This is a non-set-aside contract awarded through competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,780.82 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on September 23, 2025, with an ultimate completion date of October 15, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The contractor's place of performance is located in Conshohocken, Pennsylvania, the company's headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $44,319.62 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on August 7, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order, which was not set aside for small business, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's distribution center in...
- The Defense Logistics Agency awarded a delivery order valued at $73,105.92 to AmerisourceBergen Drug Corp for the supply of AVEED 750 mg/3 mL vials on November 6, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, featuring a completion date of December 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $19,269.40 to AmerisourceBergen Drug Corp for AVEED 750 mg/3 mL vials on July 16, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a prescription testosterone replacement therapy indicated for...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,853.88 for AVEED 750 mg/3 mL vials on September 15, 2025, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AVEED (testosterone undecanoate) is a prescription testosterone replacement therapy indicated for treating low...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ85EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of AVEED 750 mg/3 mL vials with a ceiling value of $10,153.60 and a firm fixed price. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of December 23, 2025. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AVEED is a pharmaceutical product used in testosterone replacement therapy, and this delivery order represents a routine procurement from the company's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion and running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal military healthcare procurement through this comprehensive global pharmaceutical support vehicle, which enables the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 12/1/25 |